0

Regenerative Medicine Market in the US 2017-2021

  • Published: Jul 2017
  • Pages: 107
  • SKU: IRTNTR13871
Technavio

Enjoy complimentary customisation on priority with our Enterprise License!

Get me the latest version! (includes COVID-19 impact)
Safe and Secure SSL Encrypted

info
close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

2500 USD

This market research study identifies Acelity, Medtronic, MiMedx, Organogenesis, and Zimmer Biomet as the leading players in the regenerative medicine market in the US. A comprehensive analysis of this market is also presented by product (cell therapy and tissue scaffolds), by application (musculoskeletal, cardiovascular, dermatological, and ocular), and by end-user (hospitals, ASCs, and regenerative medicine centers).

Overview of the regenerative medicine market in the US

According to Technavio’s market research report, the regenerative medicine market in the US will grow rapidly at a CAGR of close to 24% during the forecast period. The increasing governmental funding in regenerative medicines is one of the key drivers that will stimulate growth in the market from 2017 to 2021. Governmental organizations are supporting the research and clinical trials of regenerative medicines due to the growing importance of regenerative medicines and the inability of research institutes and small companies to afford the research and developmental activities. In the US, most of the funds are provided by the National Institute of Health (NIH) and California Institute of Regenerative Medicine (CIRM) to conduct stem cell research. At present, the NIH is studying the disease mechanism using the induced pluripotent stem cells (iPSc) technology.

The growing focus on gene therapy is one of the key trends that will be witnessed in the regenerative medicine market in the US during the projected period. Researchers in the US are conducting gene therapy clinical trials to develop cancer therapy for hemophilia and thalassemia. The approval of gene therapy products in region such as EMEA and APAC will have a positive impact on the development of regenerative therapy.

Competitive landscape and key vendors

The regenerative medicine market in the US is highly competitive and fragmented due to the presence of a number of large, medium, and small-sized companies. These vendors are increasingly competing against each other based on factors such as aggressive pricing, product differentiation, capital support for product upgrading, and distribution partnerships.

Key vendors in this market are -

  • Acelity
  • Medtronic
  • MiMedx
  • Organogenesis
  • Zimmer Biomet

Other prominent vendors in the market include ACE Surgical Supply, Acera Surgical, Acologix, Advanced Biologics, AlloCure, AlloSource, Alphatec Spine, ANTEROGEN, Antibe Therapeutics, Astellas Pharma, Athersys, Avita Medical, AxoGen, Bacterin International, Baxter, Bellicum Pharmaceuticals, BioCardia, Biogen, BioRestorative Therapies, Biostage, Bio-Tissue, BioTissue, bluebird bio, BONESUPPORT, BrainStorm Cell Therapeutics, Caladrius, Calimmune, Capricor Therapeutics, CELGENE, Cell Medica, Cell Therapy, CellBioMed, CellSeed, Celyad, CESCA THERAPEUTICS, CTM CRC, CryoLife, Cynata, Cytori Therapeutics, Dendreon Pharmaceuticals, DiscGenics, Fate Therapeutics, Fibrocell Science, Forticell Bioscience, Fortress Biotech, FUJIFILM Holdings, Gamida Cell, Geron, GlaxoSmithKline, Healthpoint, Histogen, Histogenics, Holostem Terapie Avanzate, Humacyte, Immunocellular Therapeutics, Integra LifeSciences, Intercytex, InVivo Therapeutics, iSTO Biologics, Janssen Pharmaceuticals, Juno Therapeutics, Juventas Therapeutics, Kiadis Pharma, LifeCell, LifeNet Health, Living Cell Technologies, Lonza, MaxCyte, MEDIPOST, Mesoblast, Nanofiber Solutions, Nanotope, Neuralstem, NewLink Genetics, Northwest Biotherapeutics, NovaRx, Opexa Therapeutics, ORGANOVO HOLDINGS, Orteq, Orthofix Holdings, Osiris Therapeutics, Pfizer, PHARMICELL, Pluristem, Prima BioMed, Q Therapeutics, Regenerex, Regenerys, Regience, Regrow, RENOVA THERAPEUTICS, RepliCel, ReproCELL, RhinoCyte, Rohto Pharma, RTI Surgical, SanBio, Sangamo Therapeutics, Shanghai Sunway Biotech, Shire, Stratatech, SURGILOGIX, Synergistic Technologies, TAKARA BIO, tella, Tissue Genesis, TissueGene, Txcell, VentriNova, Vericel, ViaCyte, and VistaGen Therapeutics.

Segmentation by product and analysis of the regenerative medicine market in the US

  • Cell therapy
  • Tissue scaffolds

Cell therapy is gaining momentum in the US due to its application in dermatology and cancer therapy. Also, various institutes and research laboratories in the US are increasingly focusing on the development of regenerative medicine by conducting studies on biological products that can be used for cell therapy. This will drive the demand for cell therapy products in the US in the forthcoming years.

Segmentation by end-user and analysis of the regenerative medicine market in the US

  • Hospitals
  • ASCs
  • Regenerative medicine centers

The patient pool highly prefers hospitals over other health care centers because they are partnering with regenerative medicine manufacturing companies. This enables hospitals to provide cell therapy and tissue scaffolds to improve patient care and treatment. The rising number of wound treatment, craniomaxillofacial surgery, knee replacement cases, and soft tissue repair will also boost the influx of patients in hospitals.

Key questions answered in the report include

  • What will the market size and the growth rate be in 2021?
  • What are the key factors driving the regenerative medicine market in the US?
  • What are the key market trends impacting the growth of the regenerative medicine market in the US?
  • What are the challenges to market growth?
  • Who are the key vendors in the regenerative medicine market in the US?
  • What are the market opportunities and threats faced by the vendors in the regenerative medicine market in the US?
  • What are the trending factors influencing the market shares of the US?
  • What are the key outcomes of the five forces analysis of the regenerative medicine market in the US?

Technavio also offers customization on reports based on specific client requirement

 

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

  • Overview of regenerative medicine in the US market

PART 05: Market landscape

  • Market overview
  • Market size and forecast

PART 06: Pipeline portfolio

  • Five forces analysis

PART 07: Market segmentation  by product

  • Cell therapy market in US
  • Tissue scaffolds market in US

PART 08: Market segmentation by application

  • Dermatological
  • Musculoskeletal
  • Ocular
  • Cardiovascular

PART 09: Market segmentation by end-user

  • Hospitals
  • ASCs
  • Regenerative medicine centers

PART 10: Decision framework

PART 11: Drivers and challenges

  • Market drivers
  • Market challenges

PART 12: Market trends

  • Increasing strategic alliances
  • Increasing number of regenerative medicine in product line
  • Gene therapy trending toward market expansion

PART 13: Vendor landscape

  • Competitive landscape

PART 14: Key vendor analysis

  • Acelity
  • Medtronic
  • MiMedx Group
  • Organogenesis
  • Zimmer Biomet
  • Other prominent vendors

PART 15: Appendix

  • List of abbreviations

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

TechnavioINFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases
Technavio

TechnavioDATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts
Technavio

TechnavioREPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape
Interested in this report?
Get your sample now!
  • What are the key global market and the regional market share?
  • What are the revenue-generating key market segments?
  • What are the key factors driving and challenging this market’s growth?
  • Who are the key market vendors and their growth strategies?
  • What are the latest trends influencing the growth of this market?
  • What are the variables influencing the market growth in the primary regions?
  • What are the factors influencing the growth of the parent market?
  • Off-the-shelf research reports
  • Reports can be tailored to meet the customer's needs
  • Trusted by more than 100 fortune 500 organizations
  • Information about the market's key drivers, trends, and challenges
  • Parent market analysis
  • Every week, 50,000 people visit our subscription platform
  • Detailed vendors report with competitive landscape
  • Covid-19 impact and recovery analysis
  • Data on revenue-generating market segments
  • Details on the market shares of various regions
  • Five-force market analysis

Certified ISO 9001 : 2015

We are ISO recognized

We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

We are GDPR and CCPA compliant

We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

Safe and Secure SSL Encrypted
Technavio

info
close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

2500 USD

Technavio Get the report (PDF) sent to your email within minutes.

Subscribe & Save

Get lifetime access to our
Technavio Insights

Customized Report as per your Business Needs

  • Our analysts will work directly with you and understand your needs
  • Get data on specified regions or segments, competitor and Vendors
  • Data will be formatted and presented as per your requirements
  • We offer $1000 worth of FREE customization at the time of purchase

Let us help you make report more suited to your requirements.

  • Get a competitive breakdown as per your niche industry
  • Customize the data with various metrics that meet your business prerequisite
  • Understand Revenue Sources, Customers and many more
  • Details on Market Share
  • These customizations are done in a short amount of time by our analysts and industry experts
Technavio
Enquire Before Buying
17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>